Overview
Sonova Holding AG is a Switzerland-based company that operates in the healthcare sector, specifically in the hearing care industry. The company specializes in the design, development, manufacture, distribution, and service of innovative hearing solutions. Sonova's product portfolio includes hearing aids, cochlear implants, wireless communication solutions, and audiological care services.
AI+ Ask Fintel’s AI assistant about Sonova Holding AG.
Thinking about good questions…
Basic Stats
The share price of Sonova Holding AG as of 5 September 2025 is CHF238.75 / share. This is an increase of 1.40% from the prior week. The market cap (or net worth) of Sonova Holding AG as of 5 September 2025 is CHF14,505.97 MM.
The Factor Analysis chart (below right) shows a view of Sonova Holding AG from a variety of lenses. Each factor shows how well the company ranks against all other companies in the Fintel global investing universe. Factor scores range from zero to 100, with 100 being most desirable, and 50 being average.
For example, a company with a Value Score of 100 would be the most undervalued company in our database. A company with a Value Score of zero would be the most overvalued.
| Market Cap | 14,505.97 MM |
| EV | 15,350.97 MM |
| Shares Out. | 61.03 MM |
| Earnings Date | |
| EPS (TTM) | 8.96 |
| Dividend Yield | 185.11 % |
| Ex-Dividend Date | 2025-06-13 |
| Borrow Rate | |
| Short Shares Avail. | |
| Short Interest | |
| Short Float | |
| Days to Cover | |
| Risk Free Rate | 4.17 % |
| Price Change (1 yr) | -20.21 % |
| Volatility (1 yr) | 0.23 |
| Beta | 0.86 |
| Sharpe Ratio (1 yr) | -1.08 |
| Sortino Ratio (1 yr) | -1.72 |
| PE Ratio | 26.52 |
| Price/Book | 5.40 |
| Price/TBV | -62.18 |
| Book/Market | 0.19 |
| EBIT/EV | 0.04 |
| EBIT(3yr avg)/EV | 0.04 |
| ROA | 0.10 |
| ROE | 0.24 |
| ROIC | 0.12 |
| CROIC | 0.04 |
| OCROIC | 0.18 |
| Implied Volatility | |
| Put/Call OI Ratio |
| Growth | 51.99 /100 |
| Profitability | 81.56 /100 |
| Quality Score | 70.08 /100 |
| Value Score | 62.91 /100 |
| Momentum Score | 36.54 /100 |
| Stability (Low Vol) Score | 84.65 /100 |
| Analyst Sentiment | 46.52 /100 |
| Fund Sentiment | 14.39 /100 |
| Insider Sentiment | |
| Officer Sentiment | |
| Dividend Score | |
| QVM Score | |
| Piotroski F-SCORE | 8.00 /9 |
Factor Scores range from 0 to 100, with 100 being most desirable. Larger circles are better. In situations where we have no data (e.g. no insider trades), we plot the score at 50 to avoid penalizing companies. However, a company that does not pay dividends will get a Dividend Score of Zero. Additionally, we inverted volatility to create a "stability" metric which is better when higher.
Price Target
The average one-year price target for Sonova Holding AG is CHF274.02. The forecasts range from a low of CHF190.97 to a high of CHF393.92. A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings. Analysts typically set price targets that correspond to their buy or sell recommendations.
Update Frequency: Monthly
Stock Upgrades/Downgrades
This card shows analyst upgrades/downgrades for Sonova Holding AG. An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.
The standard analyst ratings are generally as follows:
- Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
- Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
- Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.
When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.
The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.
| Date | Analyst | Prior | Latest Recommendation |
Action |
|---|---|---|---|---|
| 2023-12-18 | DAY BY DAY | Sell | Sell | Maintains |
| 2023-11-27 | HSBC | Buy | Buy | Maintains |
| 2023-11-27 | RESEARCH PARTNERS AG | Buy | Buy | Maintains |
| 2023-11-27 | BNP PARIBAS EXANE | Underperform | Outperform | Upgrade |
| 2023-11-10 | REDBURN ATLANTIC | Buy | Buy | Maintains |
| 2023-08-28 | HSBC | Buy | Buy | Maintains |
| 2023-08-27 | HSBC | Buy | Buy | Maintains |
| 2023-08-16 | REDBURN ATLANTIC | Buy | Buy | Maintains |
| 2023-08-15 | REDBURN ATLANTIC | Buy | Buy | Maintains |
| 2023-08-07 | DAY BY DAY | Buy | Sell | Downgrade |
| 2023-08-06 | DAY BY DAY | Buy | Sell | Downgrade |
| 2023-07-28 | CREDIT SUISSE - EUROPE | Neutral | Neutral | Maintains |
| 2023-07-27 | CREDIT SUISSE - EUROPE | Neutral | Neutral | Maintains |
| 2023-06-28 | BNP PARIBAS EXANE | Underperform | Underperform | Maintains |
| 2023-06-27 | BNP PARIBAS EXANE | Underperform | Underperform | Maintains |
| 2023-06-05 | REDBURN LIMITED | Buy | Buy | Maintains |
| 2023-06-04 | REDBURN LIMITED | Buy | Buy | Maintains |
| 2023-05-29 | BNP PARIBAS EXANE | Outperform | Underperform | Downgrade |
| 2023-05-28 | BNP PARIBAS EXANE | Outperform | Underperform | Downgrade |
| 2023-05-22 | HSBC | Buy | Buy | Maintains |
| 2023-05-22 | RESEARCH PARTNERS AG | Buy | Buy | Maintains |
| 2023-05-21 | HSBC | Buy | Buy | Maintains |
| 2023-05-21 | RESEARCH PARTNERS AG | Buy | Buy | Maintains |
| 2023-05-17 | CREDIT SUISSE - EUROPE | Outperform | Neutral | Downgrade |
| 2023-05-16 | CREDIT SUISSE - EUROPE | Outperform | Neutral | Downgrade |
| 2023-05-15 | DAY BY DAY | Sell | Buy | Upgrade |
| 2023-05-14 | DAY BY DAY | Sell | Buy | Upgrade |
| 2023-04-17 | DAY BY DAY | Sell | Buy | Upgrade |
| 2023-04-04 | REDBURN LIMITED | Buy | Buy | Maintains |
| 2023-04-03 | CREDIT SUISSE - EUROPE | Outperform | Neutral | Downgrade |
| 2023-03-27 | HSBC | Buy | Buy | Maintains |
| 2023-03-22 | BNP PARIBAS EXANE | Outperform | Underperform | Downgrade |
| 2023-01-09 | DAY BY DAY | Sell | Sell | Maintains |
| 2023-01-08 | DAY BY DAY | Sell | Sell | Maintains |
| 2022-11-15 | RESEARCH PARTNERS AG | Buy | Buy | Maintains |
| 2022-09-27 | CREDIT SUISSE - EUROPE | Outperform | Outperform | Maintains |
| 2022-09-26 | CREDIT SUISSE - EUROPE | Outperform | Outperform | Maintains |
| 2022-08-16 | STIFEL EUROPE | Hold | Hold | Maintains |
| 2022-08-15 | STIFEL EUROPE | Hold | Hold | Maintains |
| 2022-05-17 | ODDO BHF | Buy | Buy | Maintains |
| 2022-05-16 | ODDO BHF | Buy | Buy | Maintains |
| 2021-12-16 | BNP PARIBAS EXANE | Outperform | Outperform | Maintains |
| 2021-12-15 | BNP PARIBAS EXANE | Outperform | Outperform | Maintains |
| 2021-11-15 | STIFEL EUROPE | Buy | Hold | Downgrade |
| 2021-11-14 | STIFEL EUROPE | Buy | Hold | Downgrade |
| 2021-07-02 | BERENBERG | Hold | Hold | Maintains |
| 2021-07-01 | BERENBERG | Hold | Hold | Maintains |
| 2021-06-04 | COMMERZBANK CORPORATE CLIENTS | Hold | Hold | Maintains |
| 2021-06-03 | COMMERZBANK CORPORATE CLIENTS | Hold | Hold | Maintains |
| 2021-05-18 | STIFEL EUROPE | Buy | Buy | Maintains |
| 2021-05-17 | STIFEL EUROPE | Buy | Buy | Maintains |
| 2019-10-31 | Goldman Sachs | Neutral | Sell | Downgrade |
| 2024-08-06 | RESEARCH PARTNERS AG | Buy | Buy | Maintains |
| 2024-07-31 | REDBURN ATLANTIC | Buy | Neutral | Downgrade |
| 2024-07-23 | BNP PARIBAS EXANE | Outperform | Outperform | Maintains |
| 2024-07-14 | DAY BY DAY | Buy | Buy | Maintains |
| 2024-06-02 | EQUITA SIM | Hold | Hold | Maintains |
| 2024-05-26 | HSBC | Buy | Buy | Maintains |
| 2024-03-03 | DAY BY DAY | Sell | Buy | Upgrade |
| 2024-01-14 | DAY BY DAY | Sell | Sell | Maintains |
| 2023-12-17 | DAY BY DAY | Sell | Sell | Maintains |
| 2023-11-26 | HSBC | Buy | Buy | Maintains |
| 2023-11-26 | RESEARCH PARTNERS AG | Buy | Buy | Maintains |
| 2023-11-26 | BNP PARIBAS EXANE | Underperform | Outperform | Upgrade |
| 2023-11-09 | REDBURN ATLANTIC | Buy | Buy | Maintains |
| 2024-11-21 | RESEARCH PARTNERS AG | Buy | Buy | Maintains |
| 2024-12-10 | EQUITA SIM | Hold | Hold | Maintains |
| 2024-11-24 | HSBC | Buy | Buy | Maintains |
| 2024-11-24 | BNP PARIBAS EXANE | Outperform | Outperform | Maintains |
| 2025-01-06 | REDBURN ATLANTIC | Neutral | Neutral | Maintains |
| 2025-03-31 | EQUITA SIM | Hold | Hold | Maintains |
| 2025-03-31 | RESEARCH PARTNERS AG | Buy | Buy | Maintains |
| 2025-03-26 | JEFFERIES | Hold | Hold | Maintains |
| 2025-03-23 | HSBC | Buy | Hold | Downgrade |
| 2025-03-21 | REDBURN ATLANTIC | Neutral | Neutral | Maintains |
| 2025-07-06 | JEFFERIES | Hold | Hold | Maintains |
| 2025-05-25 | HSBC | Hold | Hold | Maintains |
| 2025-05-13 | EQUITA SIM | Hold | Hold | Maintains |
| 2025-05-04 | DAY BY DAY | Buy | Sell | Downgrade |
| 2025-04-09 | ROTHSCHILD & CO REDBURN | Neutral | Neutral | Maintains |
